98%
921
2 minutes
20
The bactericidal properties of bacteriophages have been used almost since the moment of the discovery of bacterial viruses. In the light of the rapidly growing number of antibiotic-resistant bacteria, phage therapy is considered one of the most promising alternatives to classical treatment. Phage amplification is one of the most common procedures of working with phages, and high-titer preparations are beneficial at the experimental stage of studies as well as in practice. The objective of this study was to compare five commonly applied methods of phage amplification: (i) pooled plaques method, (ii) the plate wash method, (iii) the agar culture method, (iv) the two-stage culture method, and (v) in liquid culture. All methods were tested for fifteen different phages. The results described herein indicate that there is no optimal, universal method for phage amplification, and the most effective method has to be established individually for each phage.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jviromet.2020.113856 | DOI Listing |
Biotechnol Lett
September 2025
Key Laboratory of Biomass Chemical Engineering of Ministry of Education, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, 310027, China.
Phage contamination poses a significant threat to industrial fermentation, leading to substantial economic losses. Virulent T-even type phages (T2/T4/T6) represent particularly concerning biological hazards in fermentation systems. This paper developed a novel CRISPR/Cas12a-based system integrated with recombinase polymerase amplification (RPA), enabling ultrasensitive identification of T-even type phages.
View Article and Find Full Text PDFJ Control Release
September 2025
State Key Laboratory of Bioreactor Engineering, Newworld Institute of Biotechnology, East China University of Science and Technology, Shanghai 200237, PR China. Electronic address:
Live bacterial therapeutics (LBT) represent a transformative modality for managing refractory chronic diseases. However, the absence of optimized microbial chassis systems is a significant barrier to clinical translation. To bridge this gap, we engineered Escherichia coli Nissle 1917 (EcN) into a versatile platform that meets the requirements for strain development and clinical application.
View Article and Find Full Text PDFBiotechnol Biotechnol Equip
February 2025
Department of Bioengineering, University of Washington, Seattle, WA, USA.
Phage-like particles (PLPs) are fabricated self-assembling nanoparticles derived from the structural elements of bacteriophages. These particles have biotechnological utility because of the ability to easily modify surface chemistry and compartmentalize nucleic acids or other materials. A consequential implementation of PLPs in diagnostics is as process controls in nucleic acid amplification tests, where control RNAs are packaged within the protein capsid and protected from degradation by RNases in the sample matrix.
View Article and Find Full Text PDFBiosens Bioelectron
December 2025
The Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, 511436, PR China; GMU-GIBH Joint School of Life Sciences, The Guangdong-Hong Kong-Macao Joint Laboratory
Aflatoxin B (AFB), a Group I carcinogen, poses severe health threats in food and environmental matrices, which requires ultra-sensitive monitoring tools. To address this, we engineered MS2 Virus-Like Particles (VLPs) via a novel triple-display strategy integrating: (i) surface-exposed nanobody N26 (fused to the A-protein) for specific recognition; (ii) high-density biotinylation (∼90 molecules/VLP, via Avi Tag insertion) for signal amplification; and (iii) C-terminal His-tags on coat protein dimers conferring organic solvent tolerance and simplified purification. The resulting Biotin-His&N26@MS2 VLP facilitates multivalent biotin-streptavidin interactions, dramatically amplifying detection signals.
View Article and Find Full Text PDFPeerJ
August 2025
Unidad de Genómica Avanzada, CINVESTAV-IPN, Irapuato, Gto, Mexico.
Recombinase polymerase amplification (RPA) facilitates rapid, exponential, isothermal nucleic acid amplification without the need for specialized equipment. Since its development in 2006, RPA has been widely applied to detect hundreds of RNA and DNA targets, spanning point-of-care diagnostics and agricultural uses. However, its reliance on pre-assembled commercial kits limits flexibility for customization.
View Article and Find Full Text PDF